NCT01959061View on ClinicalTrials.gov

Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases

PHASE4UnknownINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Colorectal Cancer Metastatic
Interventions
DRUG

Raltitrexed

4mg, every 4 weeks,transhepatic arterial infusion

DRUG

Oxaliplatin

100\~150mg, every 4 weeks, transhepatic arterial infusion

DRUG

lipiodol

5-20ml, every 4 weeks, hepatic artery embolization

Trial Locations (1)

2000032

RECRUITING

Zhongshan Hospital Fudan University, Shanghai

Sponsors
All Listed Sponsors
lead

Nanjing Chia-tai Tianqing Pharmaceutical

INDUSTRY